Showing results (91-100 of 104) with videos related to
Sort By:
Pageof 11
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1994
A multicenter double-blind placebo-controlled trial of pergolide as an adjunct to Sinemet in Parkinson's diseaseC W Olanow, S Fahn, M Muenter, et al.Clinical Genetics|November 22, 2012
Knowledge of the Genetic Information Nondiscrimination act among individuals affected by Huntington diseaseE R Dorsey, K C Darwin, P E Nichols, et al.Neurology|February 11, 2000
Rate of functional decline in Huntington's disease. Huntington Study GroupK Marder, H Zhao, R H Myers, et al.Neurology|August 29, 2001
Clinical markers of early disease in persons near onset of Huntington's diseaseJ S Paulsen, H Zhao, J C Stout, et al.Neurology|February 1, 1986
Huntington's disease in Venezuela: neurologic features and functional declineA B Young, I Shoulson, J B Penney, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1990
Huntington's disease in Venezuela: 7 years of follow-up on symptomatic and asymptomatic individualsJ B Penney, A B Young, I Shoulson, et al.Movement Disorders : Official Journal of the Movement Disorder Society|May 1, 1997
A controlled trial of fluoxetine in nondepressed patients with Huntington's diseaseP G Como, A J Rubin, C F O'Brien, et al.Movement Disorders : Official Journal of the Movement Disorder Society|May 1, 1996
A controlled trial of remacemide hydrochloride in Huntington's diseaseK Kieburtz, A Feigin, M McDermott, et al.Journal of the Neurological Sciences|July 11, 2006
Rasagiline-associated motor improvement in PD occurs without worsening of cognitive and behavioral symptomsL Elmer, S Schwid, S Eberly, et al.Pageof 11